Abstract
Innate responses combine with adaptive immunity to generate the most effective form of anti-Aspergillus immune resistance, and T cells feedback onto a tenuous balance of diverse effects of inflammation on infection. Some degree of inflammation is required for protection – particularly in mucosal tissues – during the transitional response occurring temporally between the rapid innate and slower adaptive response. However, progressive inflammation worsens disease and ultimately prevents pathogen eradication. The newly described Th17 developmental pathway may play an inflammatory role previously attributed to uncontrolled Th1 responses and serves to accommodate the seemingly paradoxical association of chronic inflammatory responses with fungal persistence. The indoleamine 2,3-dioxygenase enzyme (IDO) and regulatory T cells help to tame overzealous and exaggerated inflammatory responses and have become an integral component of immune resistance to the fungus in infections and diseases. Recent data support a view in which interleukin (IL)-23/IL-17 antagonistic strategies, including the administration of synthetic kynurenines and IDO expressing dendritic cells, could represent a new means of harnessing progressive or potentially harmful inflammation in infection and allergy to the fungus in different settings, including haematopoietic transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Denning, D. W., O’driscoll, B. R., Hogaboam, C. M., Bowyer, P. & Niven, R. M. (2006) The link between fungi and severe asthma: a summary of the evidence. Eur Respir J, 27, 615–626.
Meersseman, W., Lagrou, K., Maertens, J. & Van Wijngaerden, E. (2007) Invasive aspergillosis in the intensive care unit. Clin Infect Dis, 45, 205–216.
Thompson, G. R., 3rd & Patterson, T. F. (2008) Pulmonary aspergillosis. Semin Respir Crit Care Med, 29, 103–110.
Krishnan-Natesan, S. & Chandrasekar, P. H. (2008) Current and future therapeutic options in the management of invasive aspergillosis. Drugs, 68, 265–282.
Magill, S. S., Chiller, T. M. & Warnock, D. W. (2008) Evolving strategies in the management of aspergillosis. Expert Opin Pharmacother, 9, 193–209.
Pasqualotto, A. C. & Denning, D. W. (2008) New and emerging treatments for fungal infections. J Antimicrob Chemother, 61 Suppl 1, i19–30.
Kanafani, Z. A. & Perfect, J. R. (2008) Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis, 46, 120–128.
Romani, L. & Puccetti, P. (2007) Controlling pathogenic inflammation to fungi. Expert Rev Anti Infect Ther, 5, 1007–1017.
Singh, N. & Perfect, J. R. (2007) Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis, 7, 395–401.
Hoebe, K., Janssen, E. & Beutler, B. (2004) The interface between innate and adaptive immunity. Nat Immunol, 5, 971–974.
Moretti, S., Bellocchio, S., Bonifazi, P., Bozza, S., Zelante, T., Bistoni, F. & Romani, L. (2008) The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunol, 1, 156–168.
Romani, L. & Puccetti, P. (2006) Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol, 14, 183–189.
Bignell, E., Negrete-Urtasun, S., Calcagno, A. M., Arst, H. N., Jr., Rogers, T. & Haynes, K. (2005) Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/- mice. Infect Immun, 73, 5204–5207.
Romani, L., Fallarino, F., De Luca, A., Montagnoli, C., D’angelo, C., Zelante, T., Vacca, C., Bistoni, F., Fioretti, M. C., Grohmann, U., Segal, B. H. & Puccetti, P. (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature, 451, 211–215.
Marr, K. A., Patterson, T. & Denning, D. (2002) Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am, 16, 875–894, vi.
Latge, J. P. (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev, 12, 310–350.
Romani, L. (2004) Immunity to fungal infections. Nat Rev Immunol, 4, 1–23.
Montagnoli, C., Bozza, S., Gaziano, R., Zelante, T., Bonifazi, P., Moretti, S., Bellocchio, S., Pitzurra, L. & Romani, L. (2006) Immunity and tolerance to Aspergillus fumigatus. Novartis Found Symp, 279, 66–77; discussion 77–79, 216–219.
Akira, S., Uematsu, S. & Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell, 124, 783–801.
Bellocchio, S., Montagnoli, C., Bozza, S., Gaziano, R., Rossi, G., Mambula, S. S., Vecchi, A., Mantovani, A., Levitz, S. M. & Romani, L. (2004) The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol, 172, 3059–3069.
Chignard, M., Balloy, V., Sallenave, J. M. & Si-Tahar, M. (2007) Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Clin Immunol, 124, 238–243.
Bellocchio, S., Moretti, S., Perruccio, K., Fallarino, F., Bozza, S., Montagnoli, C., Mosci, P., Lipford, G. B., Pitzurra, L. & Romani, L. (2004) TLRs govern neutrophil activity in aspergillosis. J Immunol, 173, 7406–7415.
Mambula, S. S., Sau, K., Henneke, P., Golenbock, D. T. & Levitz, S. M. (2002) Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem, 277, 39320–39326.
Kesh, S., Mensah, N. Y., Peterlongo, P., Jaffe, D., Hsu, K., M, V. D. B., O’reilly, R., Pamer, E., Satagopan, J. & Papanicolaou, G. A. (2005) TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci, 1062, 95–103.
Carvalho, A., Pasqualotto, A. C., Pitzurra, L., Romani, L., Denning, D. W. & Rodrigues, F. (2008) Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis, 197, 618–621.
Walsh, T. J., Roilides, E., Cortez, K., Kottilil, S., Bailey, J. & Lyman, C. A. (2005) Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus. Med Mycol, 43 Suppl 1, S165–S172.
Balloy, V., Huerre, M., Latge, J. P. & Chignard, M. (2005) Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun, 73, 494–503.
Trinchieri, G. & Sher, A. (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol, 7, 179–190.
Grohmann, U., Volpi, C., Fallarino, F., Bozza, S., Bianchi, R., Vacca, C., Orabona, C., Belladonna, M. L., Ayroldi, E., Nocentini, G., Boon, L., Bistoni, F., Fioretti, M. C., Romani, L., Riccardi, C. & Puccetti, P. (2007) Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med, 13, 579–586.
Filipe-Santos, O., Bustamante, J., Chapgier, A., Vogt, G., De Beaucoudrey, L., Feinberg, J., Jouanguy, E., Boisson-Dupuis, S., Fieschi, C., Picard, C. & Casanova, J. L. (2006) Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol, 18, 347–361.
Sambatakou, H., Pravica, V., Hutchinson, I. V. & Denning, D. W. (2006) Cytokine profiling of pulmonary aspergillosis. Int J Immunogenet, 33, 297–302.
Gutcher, I. & Becher, B. (2007) APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest, 117, 1119–1127.
Linden, A., Laan, M. & Anderson, G. P. (2005) Neutrophils, interleukin-17A and lung disease. Eur Respir J, 25, 159–72.
De Luca, A., Montagnoli, C., Zelante, T., Bonifazi, P., Bozza, S., Moretti, S., D’angelo, C., Vacca, C., Boon, L., Bistoni, F., Puccetti, P., Fallarino, F. & Romani, L. (2007) Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol, 179, 5999–6008.
Zelante, T., De Luca, A., Bonifazi, P., Montagnoli, C., Bozza, S., Moretti, S., Belladonna, M. L., Vacca, C., Conte, C., Mosci, P., Bistoni, F., Puccetti, P., Kastelein, R. A., Kopf, M. & Romani, L. (2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol, 37, 2695–2706.
Montagnoli, C., Bacci, A., Bozza, S., Gaziano, R., Mosci, P., Sharpe, A. H. & Romani, L. (2002) B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol, 169, 6298–6308.
Montagnoli, C., Fallarino, F., Gaziano, R., Bozza, S., Bellocchio, S., Zelante, T., Kurup, W. P., Pitzurra, L., Puccetti, P. & Romani, L. (2006) Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol, 176, 1712–1723.
Miceli, M. H., Maertens, J., Buve, K., Grazziutti, M., Woods, G., Rahman, M., Barlogie, B. & Anaissie, E. J. (2007) Immune reconstitution inflammatory syndrome in Cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications. Cancer, 110, 112–120.
Shelburne, S. A., 3rd, Darcourt, J., White, A. C., Jr., Greenberg, S. B., Hamill, R. J., Atmar, R. L. & Visnegarwala, F. (2005) The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis, 40, 1049–1052.
Thompson, G. R., 3rd, Lavalle, C. E., 3rd & Everett, E. D. (2004) Unusual manifestations of histoplasmosis. Diagn Microbiol Infect Dis, 50, 33–41.
Antachopoulos, C., Walsh, T. J. & Roilides, E. (2007) Fungal infections in primary immunodeficiencies. Eur J Pediatr, 166, 1099–1117.
Freeman, A. F., Kleiner, D. E., Nadiminti, H., Davis, J., Quezado, M., Anderson, V., Puck, J. M. & Holland, S. M. (2007) Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol, 119, 1234–1240.
Holland, S. M., Deleo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N., Freeman, A. F., Demidowich, A., Davis, J., Turner, M. L., Anderson, V. L., Darnell, D. N., Welch, P. A., Kuhns, D. B., Frucht, D. M., Malech, H. L., Gallin, J. I., Kobayashi, S. D., Whitney, A. R., Voyich, J. M., Musser, J. M., Woellner, C., Schaffer, A. A., Puck, J. M. & Grimbacher, B. (2007) STAT3 mutations in the hyper-IgE syndrome. N Engl J Med, 357, 1608–1619.
Ortega, M., Rovira, M., Filella, X., Martinez, J. A., Almela, M., Puig, J., Carreras, E. & Mensa, J. (2006) Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant, 37, 499–502.
Schubert, M. S. (2006) Allergic fungal sinusitis. Clin Rev Allergy Immunol, 30, 205–216.
Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L. & Holland, S. M. (2000) Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore), 79, 170–200.
Bettelli, E., Oukka, M. & Kuchroo, V. K. (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol, 8, 345–350.
Dong, C. (2006) Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol, 6, 329–333.
Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., Watowich, S. S., Tian, Q., Jetten, A. M. & Dong, C. (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity, 28, 29–39.
Langrish, C. L., Mckenzie, B. S., Wilson, N. J., De Waal Malefyt, R., Kastelein, R. A. & Cua, D. J. (2004) IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev, 202, 96–105.
Chen, Z. & O’shea, J. J. (2008) Regulation of IL-17 production in human lymphocytes. Cytokine, 41, 71–78.
Hunter, C. A. (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol, 5, 521–531.
Mcgeachy, M. J. & Cua, D. J. (2007) The link between IL-23 and Th17 cell-mediated immune pathologies. Semin Immunol, 19, 372–376.
Stark, M. A., Huo, Y., Burcin, T. L., Morris, M. A., Olson, T. S. & Ley, K. (2005) Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity, 22, 285–294.
Huang, W., Na, L., Fidel, P. L. & Schwarzenberger, P. (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis, 190, 624–631.
Rudner, X. L., Happel, K. I., Young, E. A. & Shellito, J. E. (2007) Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun, 75, 3055–3061.
Bozza, S., Zelante, T., Moretti, S., Bonifazi, P., Deluca, A., D’angelo, C., Giovannini, G., Garlanda, C., Boon, L., Bistoni, F., Puccetti, P., Mantovani, A. & Romani, L. (2008) Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J Immunol, 180, 4022–4031.
Bozza, S., Fallarino, F., Pitzurra, L., Zelante, T., Montagnoli, C., Bellocchio, S., Mosci, P., Vacca, C., Puccetti, P. & Romani, L. (2005) A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol, 174, 2910–2918.
Romani, L., Zelante, T., De Luca, A., Fallarino, F. & Puccetti, P. (2008) IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol, 180, 5157–5162.
Laurence, A. & O’shea, J. J. (2007) T(H)-17 differentiation: of mice and men. Nat Immunol, 8, 903–905.
O’garra, A. & Vieira, P. (2004) Regulatory T cells and mechanisms of immune system control. Nat Med, 10, 801–805.
Roilides, E., Sein, T., Schaufele, R., Chanock, S. J. & Walsh, T. J. (1998) Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis. J Infect Dis, 178, 589–592.
Hebart, H., Bollinger, C., Fisch, P., Sarfati, J., Meisner, C., Baur, M., Loeffler, J., Monod, M., Latge, J. P. & Einsele, H. (2002) Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood, 100, 4521–4528.
Hori, S., Carvalho, T. L. & Demengeot, J. (2002) CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol, 32, 1282–1291.
Mckinley, L., Logar, A. J., Mcallister, F., Zheng, M., Steele, C. & Kolls, J. K. (2006) Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. J Immunol, 177, 6215–6226.
Cavassani, K. A., Campanelli, A. P., Moreira, A. P., Vancim, J. O., Vitali, L. H., Mamede, R. C., Martinez, R. & Silva, J. S. (2006) Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J Immunol, 177, 5811–5818.
Romani, L. (2008) Cell mediated immunity to fungi: a reassessment. Med Mycol, 46, 515–519.
Belkaid, Y. (2007) Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol, 7, 875–888.
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M. & Iwakura, Y. (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity, 17, 375–387.
Puccetti, P. & Grohmann, U. (2007) IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol, 7, 817–823.
Grohmann, U., Fallarino, F. & Puccetti, P. (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol, 24, 242–248.
Mellor, A. L. & Munn, D. H. (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol, 4, 762–774.
Fallarino, F., Grohmann, U., You, S., Mcgrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., Santamaria, P., Fioretti, M. C. & Puccetti, P. (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol, 176, 6752–6761.
Wills-Karp, M., Santeliz, J. & Karp, C. L. (2001) The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol, 1, 69–75.
Judson, M. A. & Stevens, D. A. (2001) Current pharmacotherapy of allergic bronchopulmonary aspergillosis. Expert Opin Pharmacother, 2, 1065–1071.
Von Bubnoff, D., Fimmers, R., Bogdanow, M., Matz, H., Koch, S. & Bieber, T. (2004) Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy, 34, 1056–1063.
Hessel, E. M., Chu, M., Lizcano, J. O., Chang, B., Herman, N., Kell, S. A., Wills-Karp, M. & Coffman, R. L. (2005) Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J Exp Med, 202, 1563–1573.
Bozza, S., Perruccio, K., Montagnoli, C., Gaziano, R., Bellocchio, S., Burchielli, E., Nkwanyuo, G., Pitzurra, L., Velardi, A. & Romani, L. (2003) A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood, 102, 3807–3814.
Stevens, D. A. (2004) Vaccinate against aspergillosis! A call to arms of the immune system. Clin Infect Dis, 38, 1131–1136.
Ljungman, P., Engelhard, D., De La Camara, R., Einsele, H., Locasciulli, A., Martino, R., Ribaud, P., Ward, K. & Cordonnier, C. (2005) Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant, 35, 737–746.
Steinman, R. M., Hawiger, D. & Nussenzweig, M. C. (2003) Tolerogenic dendritic cells. Annu Rev Immunol, 21, 685–711.
Martinic, M. M. & Von Herrath, M. G. (2006) Control of graft-versus-host disease by regulatory T cells: which level of antigen specificity? Eur J Immunol, 36, 2299–3303.
Waldmann, H. & Cobbold, S. (2004) Exploiting tolerance processes in transplantation. Science, 305, 209–212.
Romani, L., Bistoni, F., Perruccio, K., Montagnoli, C., Gaziano, R., Bozza, S., Bonifazi, P., Bistoni, G., Rasi, G., Velardi, A., Fallarino, F., Garaci, E. & Puccetti, P. (2006) Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood, 108, 2265–2274.
Montagnoli, C., Perruccio, K., Bozza, S., Bonifazi, P., Zelante, T., De Luca, A., Moretti, S., D’angelo, C., Bistoni, F., Martelli, M., Aversa, F., Velardi, A. & Romani, L. (2008) Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation. Blood Cells Mol Dis, 40, 55–62.
Legrand, F., Lecuit, M., Dupont, B., Bellaton, E., Huerre, M., Rohrlich, P. S. & Lortholary, O. (2008) Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis, 46, 696–702.
Abbott, A. (2006) Questions linger about unexplained gene-therapy trial death. Nat Med, 12, 597.
Roilides, E., Lyman, C. A., Panagopoulou, P. & Chanock, S. (2003) Immunomodulation of invasive fungal infections. Infect Dis Clin North Am, 17, 193–219.
Acknowledgments
We thank Dr. Cristina Massi Benedetti for digital art and editing. The original studies conducted in the author laboratory were supported by the Specific Targeted Research Project “MANASP” (LSHE-CT-2006), contract number 037899 (FP6).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Romani, L. (2009). Immunology of Aspergillus and Aspergillosis: The Story So Far. In: Comarú Pasqualotto, A. (eds) Aspergillosis: From Diagnosis to Prevention. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2408-4_3
Download citation
DOI: https://doi.org/10.1007/978-90-481-2408-4_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-2407-7
Online ISBN: 978-90-481-2408-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)